- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Angela Moskow, Sanofi-Aventis
S
Angela Moskow
VP, Diabetes Marketing, Sanofi-Aventis
LOYAL CITIZEN: Always worked for (different iterations of) the same company
CAREER FOCUS: Diabetes
Om her most memorable moment.:
I still remember at the Lantus launch meeting, standing on the stage and issuing the challenge to the sales force to revolutionize the treatment of diabetes. When we launched Lantus in 2001, the peak forecast was $750 million, and we were pretty much told that we would never go beyond that. So when we hit $1 billion on the brand, we really celebrated. Now, in 2008, we're looking at moving toward $2 billion. And we know that there are still so many more people out there that we need to help.
Angela Moskow
The State of Mining Data Insights in the Life Sciences Industry – 2024
April 30th 2024A Frost & Sullivan industry-wide survey reveals which insights most pharmaceutical companies have mastered and which are still painful or impossible to extract and details the complexity of the process, the confidence companies have in their findings, and more. Hear Web Sun, President and Co-founder of Komodo Health, share what's driving these challenges and how you can overcome them.
